ទំព័រដើម › មហារីកទ្រូង › ប៉ែនស៊ីលវ៉ានី › Philadelphia
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកទ្រូង នៅក្នុង Philadelphia, PA
ការសិក្សាចំនួន 56 សម្រាប់ មហារីកទ្រូង កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Philadelphia (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Consultants In Med Onco And Hema, Drexel Hill · ឆ្ងាយ 7 ម៉ាយ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · ឆ្ងាយ 22 ម៉ាយ
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia
- Alliance Cancer Specialists, Horsham · ឆ្ងាយ 16 ម៉ាយ
Study of AVZO-021 in Patients With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
កំពុងជ្រើសរើសដំណាក់កាល 3
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine - Chester County Hospital, West Chester · ឆ្ងាយ 24 ម៉ាយ
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Clinical Trial Site, Horsham · ឆ្ងាយ 16 ម៉ាយ
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University - Clinical Research Institute, Philadelphia
- Jefferson Hospital Northeast, Philadelphia
- និង 1 ទៀត
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
កំពុងជ្រើសរើសដំណាក់កាល 3
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · ឆ្ងាយ 7 ម៉ាយ
- Consultants In Medical Oncology and Hematology, P.C., Broomall · ឆ្ងាយ 10 ម៉ាយ
- និង 1 ទៀត
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Abramson Cancer Center, Philadelphia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- និង 11 ទៀត
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
កំពុងជ្រើសរើស
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
ATEMPT 2.0: Adjuvant T-DM1 vs TH
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
កំពុងជ្រើសរើស
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
កំពុងជ្រើសរើស
- Fox Chase Cancer Center, Philadelphia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
កំពុងជ្រើសរើសដំណាក់កាល 3
- Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital, Philadelphia
E-Mindfulness Approaches for Living After Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · ឆ្ងាយ 8 ម៉ាយ
- Chester County Hospital, West Chester · ឆ្ងាយ 24 ម៉ាយ
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
កំពុងជ្រើសរើសស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Thomas Jefferson University Hospital, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
កំពុងជ្រើសរើសដំណាក់កាល 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Investigative Site #109, Philadelphia
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
កំពុងជ្រើសរើស
- Abamson Cancer Center of the University of Pennsylvania, Philadelphia
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Rittenhouse Hematology/Oncology, Philadelphia
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Hospital of the University of Pennsylvania, Philadelphia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania (U Penn), Philadelphia
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
កំពុងជ្រើសរើសដំណាក់កាលដំបូង ១
- Hospital of the University of Pennsylvania, Philadelphia
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
B.Brilliant Revelation Comparision Study
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Pennsylvania Hospital, Center for Breast Imaging, Philadelphia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- និង 4 ទៀត
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
FES BPET-DBT in Newly Diagnosed Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាលដំបូង ១
- University of Pennsylvania, Philadelphia
Safe and Explainable AI
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Hospital of the University of Pennsylvania, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
កំពុងជ្រើសរើសដំណាក់កាល 4
- Albert Einstein Healthcare Network, Philadelphia
[18F] F-GLN by PET/CT in Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
Prospective Breast Cancer Biospecimen Collection
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
កំពុងជ្រើសរើស
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Massive Bio SYNERGY-AI site, Philadelphia
Surviving Daily Life
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Thomas Jefferson University, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pennsylvania, Philadelphia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Consultants in Medical Oncology and Hematology, P.C., Broomall · ឆ្ងាយ 10 ម៉ាយ
- Alliance Cancer Specialists, Horsham · ឆ្ងាយ 16 ម៉ាយ
Role of the Immune Environment in Response to Therapy in Breast Cancer
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Abramson Cancer Center, Philadelphia
ការសាកល្បងសម្រាប់ មហារីកទ្រូង នៅក្នុងទីក្រុងផ្សេងទៀត
- New York City, NYការសិក្សា 136
- Houston, TXការសិក្សា 126
- Boston, MAការសិក្សា 112
- Nashville, TNការសិក្សា 81
- Los Angeles, CAការសិក្សា 73
- Edison, NJការសិក្សា 68
- St. Louis, MOការសិក្សា 64
- Queens, NYការសិក្សា 64
- Durham, NCការសិក្សា 64
- Chicago, ILការសិក្សា 59
- Dallas, TXការសិក្សា 55
- Arlington, VAការសិក្សា 47
ការសិក្សាផ្សេងទៀតនៅក្នុង Philadelphia
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 59
- Non-Small Cell Lung Cancerការសិក្សា 51
- មហារីកដែលរីករាលដាលការសិក្សា 46
- មហារីកតូចការសិក្សា 44
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 44
- មហារីកស៊ុតការសិក្សា 44
- មហារីកសួតការសិក្សា 36
- ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ការសិក្សា 34
- បេះដូងខ្សោយការសិក្សា 31
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 28
- ភាពសោកសៅការសិក្សា 26
- មហារីកតំបក់ការសិក្សា 26
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។